Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F5V9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,460
Award facts
- Contract value 100% obligated
- $10,460.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $10,460.01, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Benlysta 200 mg/mL auto-injector supply. The contract was awarded on January 21, 2026, with an ultimate completion date of February 11, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The Defense Logistics Agency, which oversees pharmaceutical procurement for military medical supply chains, issued this non-set-aside competitive award. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026.
Benlysta (belimumab) is a biologic medication used to treat systemic lupus erythematosus and other autoimmune conditions, commonly administered via auto-injector to military personnel and federal beneficiaries. As a major pharmaceutical distributor and critical vendor for federal medical procurement, Amerisourcebergen Drug Corp has demonstrated significant capability in fulfilling Defense Logistics Agency pharmaceutical supply requirements. The company's extensive portfolio of federal contracts reflects its role in supplying diverse medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including service members, veterans, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5V9B?
SPE2DR26F5V9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F5V9B worth?
The government has obligated $10,460 on SPE2DR26F5V9B.
Is contract SPE2DR26F5V9B an order under another contract?
Yes. SPE2DR26F5V9B is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5V9B competed?
The extent of competition for SPE2DR26F5V9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award